Investigation of women with endometrial carcinoma using serum vascular endothelial growth factor (VEGF) measurement

International Journal of Gynecological Cancer

Volumn 11, Issue 2, 2001, Pages 164-166

  Gornall, R J ^a,b   Anthony, F W ^a,b   Coombes, E J ^a,b   Hogston, P ^a,b   Woolas, R P ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b PRINCESS ANNE HOSPITAL   (United Kingdom)

Author keywords

CA125; Endometrial carcinoma; Platelets; VEGF

Indexed keywords

VASCULOTROPIN;

ADVANCED CANCER; ARTICLE; BLOOD LEVEL; CANCER STAGING; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LAPAROTOMY; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADULT; BLOOD PLATELETS; CARCINOMA; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035032064     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2001.011002164.x     Document Type: Article

References (12)

1. Independent prognosic importance of microvessel density in endometrial carcinoma
2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
3. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas
4. Serum vascular endothelial growth factor is often elevated in disseminated cancer
5. Preoperative serum vascular endothelial growth factor in human colorectal cancer
6. Serum vascular growth factor in epithelial ovarian growth neoplasms: Correlation with patient survival
7. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human mega-karyocytes and platelets
8. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor
9. Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma
10. Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy
11. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins
12. Ovarian cancer associated thrombocytosis. Correlation with prognostic factors and with survival